Hyuk Joo Jee
Corporate Officer/Principal bei HLB CO., LTD.
Profil
Hyuk Joo Jee is currently working as a Director at Immunomic Therapeutics, Inc. and as a Vice President at HLB Co., Ltd.
He completed his undergraduate degree from Korea University.
Aktive Positionen von Hyuk Joo Jee
| Unternehmen | Position | Beginn |
|---|---|---|
| HLB CO., LTD. | Corporate Officer/Principal | - |
Immunomic Therapeutics, Inc.
 Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Director/Board Member | 05.05.2020 |
Ausbildung von Hyuk Joo Jee
| Korea University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HLB CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Health Technology |
